U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06792708) titled 'Observational Study of LUMRYZ in Narcolepsy' on Jan. 20.
Brief Summary: This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.
Study Start Date: July 18, 2024
Study Type: OBSERVATIONAL
Condition:
Narcolepsy
Intervention:
DRUG: LUMRYZ
Prescribed for narcolepsy in accordance with product label.
Recruitment Status: RECRUITING
Sponsor: Avadel
Disclaimer: Curated by HT Syndication....